DcR1 Antibodies
Choose one of 83 DcR1 antibodies from our product listing based on 7 publications and 26 validation images.
Explore reliable DcR1 antibodies from a broad selection of renowned manufacturers. Our portfolio enables accurate DcR1 detection across multiple species, including Human, Mouse, Rat, C. elegans, and supports diverse research applications such as WB, FACS, ELISA, IF (cc), IF (p).
Quickly find the right antibody using our search, filter, and comparison tools. Each product page provides detailed validation data, literature references, and customer feedback. Unlike comparison-only resources, you can conveniently purchase antibodies directly through our site. Choose from polyclonal, monoclonal, or recombinant DcR1 antibodies derived from various hosts such as Rabbit, Mouse, Goat. Browse our products below and order directly to support your research with confidence.
Alternative names for DcR1 are TNFRSF10C.
Recommended next Filters:
Would you like to try our new AI Search?
83 results
Latest Publications for our DcR1 Antibodies
: "Impact of p53 status on TRAIL-mediated apoptotic and non-apoptotic signaling in cancer cells." in: PLoS ONE, Vol. 14, Issue 4, pp. e0214847, (2019) (PubMed).: "Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells." in: BMC cancer, Vol. 19, Issue 1, pp. 496, (2019) (PubMed).
: "TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells." in: Frontiers in immunology, Vol. 10, pp. 2044, (2019) (PubMed).
: "Dual role of DR5 in death and survival signaling leads to TRAIL resistance in cancer cells." in: Cell death & disease, Vol. 8, Issue 8, pp. e3025, (2018) (PubMed).
: "TRAIL regulatory receptors constrain human hepatic stellate cell apoptosis." in: Scientific reports, Vol. 7, Issue 1, pp. 5514, (2017) (PubMed).
: "Targeting Apoptotic Activity Against Prostate Cancer Stem Cells." in: International journal of molecular sciences, Vol. 18, Issue 8, (2017) (PubMed).
: "The TRAIL-Induced Cancer Secretome Promotes a Tumor-Supportive Immune Microenvironment via CCR2." in: Molecular cell, Vol. 65, Issue 4, pp. 730-742.e5, (2017) (PubMed).
: "Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma." in: Stem cells translational medicine, Vol. 3, Issue 2, pp. 172-82, (2014) (PubMed).
: "Dominant negative effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by formation of heteromeric complexes." in: The Journal of biological chemistry, Vol. 289, Issue 23, pp. 16576-87, (2014) (PubMed).
: "TRAIL-engineered bone marrow-derived mesenchymal stem cells: TRAIL expression and cytotoxic effects on C6 glioma cells." in: Anticancer research, Vol. 34, Issue 2, pp. 729-34, (2014) (PubMed).
Aliases for DcR1 Antibodies
TNF receptor superfamily member 10c (TNFRSF10C) AntibodiesCD263 Antibodies
DCR1 Antibodies
DCR1-TNFR Antibodies
LIT Antibodies
TNFRSF10C Antibodies
TRAIL-R3 Antibodies
TRAILR3 Antibodies
TRID Antibodies
Did you look for something else?
- DCPS Antibodies
- DCP2 Antibodies
- DCP1B Antibodies
- DCP1A Antibodies
- DCMP Deaminase Antibodies
- DCLRE1C Antibodies
- DCLRE1B Antibodies
- DCLK3 Antibodies
- DCLK2 Antibodies
- DCLK1 Antibodies
- DCL1 Antibodies
- DCK Antibodies
- DCI Antibodies
- DCHS1 Antibodies
- DCDC5 Antibodies
- DCDC2B Antibodies
- DCDC2 Antibodies
- DCC Antibodies
- DCBLD2 Antibodies
- DCAKD Antibodies
- DcR2 Antibodies
- DCST1 Antibodies
- DCT Antibodies
- DCTN3 Antibodies
- DCTN5 Antibodies
- DCTN6 Antibodies
- DCTPP1 Antibodies
- DCUN1D1 Antibodies
- DCUN1D2 Antibodies
- DCUN1D3 Antibodies
- DCUN1D4 Antibodies
- DCXR Antibodies
- DcyD Antibodies
- DDA1 Antibodies
- DDAH1 Antibodies
- DDAH2 Antibodies
- DDB1 Antibodies
- DDB2 Antibodies
- DDC Antibodies
- DDHD1 Antibodies
